Global Hereditary Angioedema Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • Category : Healthcare & Pharma
  • |
  • ID : 681642
  • |
  • Publishe Date : 12-Nov-18
  • |
  • No of Pages: 120
  • |
  • Publisher : Global Info Research

Hereditary angioedema is a rare disease and is mostly mistaken for common allergic reactions and abdominal pain. This mainly on account of the lack of knowledge among both physicians and patients about the condition. About 40% of the affected patients are diagnosed correctly with hereditary angioedema in the US and Europe. With progress in diagnostic field and different initiatives undertaken by patient bodies and industry players to spread awareness, the market for hereditary angioedema is projected to grow.

Scope of the Report:
This report focuses on the Hereditary Angioedema in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Hereditary Angioedema is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
Pharming Group NV
Shire plc
CSL Limited
iBio Inc.
BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist

Market Segment by Applications, can be divided into
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

There are 15 Chapters to deeply display the global Hereditary Angioedema market.
Chapter 1, to describe Hereditary Angioedema Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Hereditary Angioedema, with sales, revenue, and price of Hereditary Angioedema, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Hereditary Angioedema, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Hereditary Angioedema market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Hereditary Angioedema sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

1 Market Overview
1.1 Hereditary Angioedema Introduction
1.2 Market Analysis by Type
1.2.1 C1 Esterase Inhibitor
1.2.2 Kallikrein Inhibitor
1.2.3 Selective Bradykinin B2 Receptor Antagonist
1.3 Market Analysis by Applications
1.3.1 Retail Pharmacies
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pharming Group NV
2.1.1 Business Overview
2.1.2 Hereditary Angioedema Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pharming Group NV Hereditary Angioedema Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Shire plc
2.2.1 Business Overview
2.2.2 Hereditary Angioedema Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Shire plc Hereditary Angioedema Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 CSL Limited
2.3.1 Business Overview
2.3.2 Hereditary Angioedema Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 CSL Limited Hereditary Angioedema Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 iBio Inc.
2.4.1 Business Overview
2.4.2 Hereditary Angioedema Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 iBio Inc. Hereditary Angioedema Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 BioCryst Pharmaceuticals, Inc.
2.5.1 Business Overview
2.5.2 Hereditary Angioedema Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Ionis Pharmaceuticals, Inc.
2.6.1 Business Overview
2.6.2 Hereditary Angioedema Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Hereditary Angioedema Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Hereditary Angioedema Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Hereditary Angioedema Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Hereditary Angioedema Manufacturer Market Share in 2017
3.3.2 Top 6 Hereditary Angioedema Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Hereditary Angioedema Market Analysis by Regions
4.1 Global Hereditary Angioedema Sales, Revenue and Market Share by Regions
4.1.1 Global Hereditary Angioedema Sales and Market Share by Regions (2013-2018)
4.1.2 Global Hereditary Angioedema Revenue and Market Share by Regions (2013-2018)
4.2 North America Hereditary Angioedema Sales and Growth Rate (2013-2018)
4.3 Europe Hereditary Angioedema Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Hereditary Angioedema Sales and Growth Rate (2013-2018)
4.5 South America Hereditary Angioedema Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Hereditary Angioedema Sales and Growth Rate (2013-2018)
5 North America Hereditary Angioedema by Countries
5.1 North America Hereditary Angioedema Sales, Revenue and Market Share by Countries
5.1.1 North America Hereditary Angioedema Sales and Market Share by Countries (2013-2018)
5.1.2 North America Hereditary Angioedema Revenue and Market Share by Countries (2013-2018)
5.2 United States Hereditary Angioedema Sales and Growth Rate (2013-2018)
5.3 Canada Hereditary Angioedema Sales and Growth Rate (2013-2018)
5.4 Mexico Hereditary Angioedema Sales and Growth Rate (2013-2018)
6 Europe Hereditary Angioedema by Countries
6.1 Europe Hereditary Angioedema Sales, Revenue and Market Share by Countries
6.1.1 Europe Hereditary Angioedema Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Hereditary Angioedema Revenue and Market Share by Countries (2013-2018)
6.2 Germany Hereditary Angioedema Sales and Growth Rate (2013-2018)
6.3 UK Hereditary Angioedema Sales and Growth Rate (2013-2018)
6.4 France Hereditary Angioedema Sales and Growth Rate (2013-2018)
6.5 Russia Hereditary Angioedema Sales and Growth Rate (2013-2018)
6.6 Italy Hereditary Angioedema Sales and Growth Rate (2013-2018)
7 Asia-Pacific Hereditary Angioedema by Countries
7.1 Asia-Pacific Hereditary Angioedema Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Hereditary Angioedema Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Hereditary Angioedema Revenue and Market Share by Countries (2013-2018)
7.2 China Hereditary Angioedema Sales and Growth Rate (2013-2018)
7.3 Japan Hereditary Angioedema Sales and Growth Rate (2013-2018)
7.4 Korea Hereditary Angioedema Sales and Growth Rate (2013-2018)
7.5 India Hereditary Angioedema Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Hereditary Angioedema Sales and Growth Rate (2013-2018)
8 South America Hereditary Angioedema by Countries
8.1 South America Hereditary Angioedema Sales, Revenue and Market Share by Countries
8.1.1 South America Hereditary Angioedema Sales and Market Share by Countries (2013-2018)
8.1.2 South America Hereditary Angioedema Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Hereditary Angioedema Sales and Growth Rate (2013-2018)
8.3 Argentina Hereditary Angioedema Sales and Growth Rate (2013-2018)
8.4 Colombia Hereditary Angioedema Sales and Growth Rate (2013-2018)
9 Middle East and Africa Hereditary Angioedema by Countries
9.1 Middle East and Africa Hereditary Angioedema Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Hereditary Angioedema Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Hereditary Angioedema Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Hereditary Angioedema Sales and Growth Rate (2013-2018)
9.3 UAE Hereditary Angioedema Sales and Growth Rate (2013-2018)
9.4 Egypt Hereditary Angioedema Sales and Growth Rate (2013-2018)
9.5 Nigeria Hereditary Angioedema Sales and Growth Rate (2013-2018)
9.6 South Africa Hereditary Angioedema Sales and Growth Rate (2013-2018)
10 Global Hereditary Angioedema Market Segment by Type
10.1 Global Hereditary Angioedema Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Hereditary Angioedema Sales and Market Share by Type (2013-2018)
10.1.2 Global Hereditary Angioedema Revenue and Market Share by Type (2013-2018)
10.2 C1 Esterase Inhibitor Sales Growth and Price
10.2.1 Global C1 Esterase Inhibitor Sales Growth (2013-2018)
10.2.2 Global C1 Esterase Inhibitor Price (2013-2018)
10.3 Kallikrein Inhibitor Sales Growth and Price
10.3.1 Global Kallikrein Inhibitor Sales Growth (2013-2018)
10.3.2 Global Kallikrein Inhibitor Price (2013-2018)
10.4 Selective Bradykinin B2 Receptor Antagonist Sales Growth and Price
10.4.1 Global Selective Bradykinin B2 Receptor Antagonist Sales Growth (2013-2018)
10.4.2 Global Selective Bradykinin B2 Receptor Antagonist Price (2013-2018)
11 Global Hereditary Angioedema Market Segment by Application
11.1 Global Hereditary Angioedema Sales Market Share by Application (2013-2018)
11.2 Retail Pharmacies Sales Growth (2013-2018)
11.3 Hospital Pharmacies Sales Growth (2013-2018)
11.4 Online Pharmacies Sales Growth (2013-2018)
12 Hereditary Angioedema Market Forecast (2018-2023)
12.1 Global Hereditary Angioedema Sales, Revenue and Growth Rate (2018-2023)
12.2 Hereditary Angioedema Market Forecast by Regions (2018-2023)
12.2.1 North America Hereditary Angioedema Market Forecast (2018-2023)
12.2.2 Europe Hereditary Angioedema Market Forecast (2018-2023)
12.2.3 Asia-Pacific Hereditary Angioedema Market Forecast (2018-2023)
12.2.4 South America Hereditary Angioedema Market Forecast (2018-2023)
12.2.5 Middle East and Africa Hereditary Angioedema Market Forecast (2018-2023)
12.3 Hereditary Angioedema Market Forecast by Type (2018-2023)
12.3.1 Global Hereditary Angioedema Sales Forecast by Type (2018-2023)
12.3.2 Global Hereditary Angioedema Market Share Forecast by Type (2018-2023)
12.4 Hereditary Angioedema Market Forecast by Application (2018-2023)
12.4.1 Global Hereditary Angioedema Sales Forecast by Application (2018-2023)
12.4.2 Global Hereditary Angioedema Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Hereditary Angioedema Picture
Table Product Specifications of Hereditary Angioedema
Figure Global Sales Market Share of Hereditary Angioedema by Types in 2017
Table Hereditary Angioedema Types for Major Manufacturers
Figure C1 Esterase Inhibitor Picture
Figure Kallikrein Inhibitor Picture
Figure Selective Bradykinin B2 Receptor Antagonist Picture
Figure Hereditary Angioedema Sales Market Share by Applications in 2017
Figure Retail Pharmacies Picture
Figure Hospital Pharmacies Picture
Figure Online Pharmacies Picture
Figure United States Hereditary Angioedema Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Hereditary Angioedema Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Hereditary Angioedema Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Hereditary Angioedema Revenue (Value) and Growth Rate (2013-2023)
Figure France Hereditary Angioedema Revenue (Value) and Growth Rate (2013-2023)
Figure UK Hereditary Angioedema Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Hereditary Angioedema Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Hereditary Angioedema Revenue (Value) and Growth Rate (2013-2023)
Figure China Hereditary Angioedema Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Hereditary Angioedema Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Hereditary Angioedema Revenue (Value) and Growth Rate (2013-2023)
Figure India Hereditary Angioedema Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Hereditary Angioedema Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Hereditary Angioedema Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Hereditary Angioedema Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Hereditary Angioedema Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Hereditary Angioedema Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Hereditary Angioedema Revenue (Value) and Growth Rate (2013-2023)
Table Pharming Group NV Basic Information, Manufacturing Base and Competitors
Table Pharming Group NV Hereditary Angioedema Type and Applications
Table Pharming Group NV Hereditary Angioedema Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Shire plc Basic Information, Manufacturing Base and Competitors
Table Shire plc Hereditary Angioedema Type and Applications
Table Shire plc Hereditary Angioedema Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CSL Limited Basic Information, Manufacturing Base and Competitors
Table CSL Limited Hereditary Angioedema Type and Applications
Table CSL Limited Hereditary Angioedema Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table iBio Inc. Basic Information, Manufacturing Base and Competitors
Table iBio Inc. Hereditary Angioedema Type and Applications
Table iBio Inc. Hereditary Angioedema Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table BioCryst Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Type and Applications
Table BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ionis Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table Ionis Pharmaceuticals, Inc. Hereditary Angioedema Type and Applications
Table Ionis Pharmaceuticals, Inc. Hereditary Angioedema Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Hereditary Angioedema Sales by Manufacturer (2016-2017)
Figure Global Hereditary Angioedema Sales Market Share by Manufacturer in 2016
Figure Global Hereditary Angioedema Sales Market Share by Manufacturer in 2017
Table Global Hereditary Angioedema Revenue by Manufacturer (2016-2017)
Figure Global Hereditary Angioedema Revenue Market Share by Manufacturer in 2016
Figure Global Hereditary Angioedema Revenue Market Share by Manufacturer in 2017
Figure Top 3 Hereditary Angioedema Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Hereditary Angioedema Manufacturer (Revenue) Market Share in 2017
Figure Global Hereditary Angioedema Sales and Growth Rate (2013-2018)
Figure Global Hereditary Angioedema Revenue and Growth Rate (2013-2018)
Table Global Hereditary Angioedema Sales by Regions (2013-2018)
Table Global Hereditary Angioedema Sales Market Share by Regions (2013-2018)
Table Global Hereditary Angioedema Revenue by Regions (2013-2018)
Figure Global Hereditary Angioedema Revenue Market Share by Regions in 2013
Figure Global Hereditary Angioedema Revenue Market Share by Regions in 2017
Figure North America Hereditary Angioedema Sales and Growth Rate (2013-2018)
Figure Europe Hereditary Angioedema Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Hereditary Angioedema Sales and Growth Rate (2013-2018)
Figure South America Hereditary Angioedema Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Hereditary Angioedema Sales and Growth Rate (2013-2018)
Figure North America Hereditary Angioedema Revenue and Growth Rate (2013-2018)
Table North America Hereditary Angioedema Sales by Countries (2013-2018)
Table North America Hereditary Angioedema Sales Market Share by Countries (2013-2018)
Figure North America Hereditary Angioedema Sales Market Share by Countries in 2013
Figure North America Hereditary Angioedema Sales Market Share by Countries in 2017
Table North America Hereditary Angioedema Revenue by Countries (2013-2018)
Table North America Hereditary Angioedema Revenue Market Share by Countries (2013-2018)
Figure North America Hereditary Angioedema Revenue Market Share by Countries in 2013
Figure North America Hereditary Angioedema Revenue Market Share by Countries in 2017
Figure United States Hereditary Angioedema Sales and Growth Rate (2013-2018)
Figure Canada Hereditary Angioedema Sales and Growth Rate (2013-2018)
Figure Mexico Hereditary Angioedema Sales and Growth Rate (2013-2018)
Figure Europe Hereditary Angioedema Revenue and Growth Rate (2013-2018)
Table Europe Hereditary Angioedema Sales by Countries (2013-2018)
Table Europe Hereditary Angioedema Sales Market Share by Countries (2013-2018)
Table Europe Hereditary Angioedema Revenue by Countries (2013-2018)
Figure Europe Hereditary Angioedema Revenue Market Share by Countries in 2016
Figure Europe Hereditary Angioedema Revenue Market Share by Countries in 2017
Figure Germany Hereditary Angioedema Sales and Growth Rate (2013-2018)
Figure UK Hereditary Angioedema Sales and Growth Rate (2013-2018)
Figure France Hereditary Angioedema Sales and Growth Rate (2013-2018)
Figure Russia Hereditary Angioedema Sales and Growth Rate (2013-2018)
Figure Italy Hereditary Angioedema Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Hereditary Angioedema Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Hereditary Angioedema Sales by Countries (2013-2018)
Table Asia-Pacific Hereditary Angioedema Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Hereditary Angioedema Sales Market Share by Countries 2017
Table Asia-Pacific Hereditary Angioedema Revenue by Countries (2013-2018)
Figure Asia-Pacific Hereditary Angioedema Revenue Market Share by Countries 2017
Figure China Hereditary Angioedema Sales and Growth Rate (2013-2018)
Figure Japan Hereditary Angioedema Sales and Growth Rate (2013-2018)
Figure Korea Hereditary Angioedema Sales and Growth Rate (2013-2018)
Figure India Hereditary Angioedema Sales and Growth Rate (2013-2018)
Figure Southeast Asia Hereditary Angioedema Sales and Growth Rate (2013-2018)
Figure South America Hereditary Angioedema Revenue and Growth Rate (2013-2018)
Table South America Hereditary Angioedema Sales by Countries (2013-2018)
Table South America Hereditary Angioedema Sales Market Share by Countries (2013-2018)
Figure South America Hereditary Angioedema Sales Market Share by Countries in 2017
Table South America Hereditary Angioedema Revenue by Countries (2013-2018)
Table South America Hereditary Angioedema Revenue Market Share by Countries (2013-2018)
Figure South America Hereditary Angioedema Revenue Market Share by Countries in 2017
Figure Brazil Hereditary Angioedema Sales and Growth Rate (2013-2018)
Figure Argentina Hereditary Angioedema Sales and Growth Rate (2013-2018)
Figure Colombia Hereditary Angioedema Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Hereditary Angioedema Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Hereditary Angioedema Sales by Countries (2013-2018)
Table Middle East and Africa Hereditary Angioedema Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Hereditary Angioedema Sales Market Share by Countries in 2017
Table Middle East and Africa Hereditary Angioedema Revenue by Countries (2013-2018)
Table Middle East and Africa Hereditary Angioedema Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Hereditary Angioedema Revenue Market Share by Countries in 2013
Figure Middle East and Africa Hereditary Angioedema Revenue Market Share by Countries in 2017
Figure Saudi Arabia Hereditary Angioedema Sales and Growth Rate (2013-2018)
Figure UAE Hereditary Angioedema Sales and Growth Rate (2013-2018)
Figure Egypt Hereditary Angioedema Sales and Growth Rate (2013-2018)
Figure Nigeria Hereditary Angioedema Sales and Growth Rate (2013-2018)
Figure South Africa Hereditary Angioedema Sales and Growth Rate (2013-2018)
Table Global Hereditary Angioedema Sales by Type (2013-2018)
Table Global Hereditary Angioedema Sales Share by Type (2013-2018)
Table Global Hereditary Angioedema Revenue by Type (2013-2018)
Table Global Hereditary Angioedema Revenue Share by Type (2013-2018)
Figure Global C1 Esterase Inhibitor Sales Growth (2013-2018)
Figure Global C1 Esterase Inhibitor Price (2013-2018)
Figure Global Kallikrein Inhibitor Sales Growth (2013-2018)
Figure Global Kallikrein Inhibitor Price (2013-2018)
Figure Global Selective Bradykinin B2 Receptor Antagonist Sales Growth (2013-2018)
Figure Global Selective Bradykinin B2 Receptor Antagonist Price (2013-2018)
Table Global Hereditary Angioedema Sales by Application (2013-2018)
Table Global Hereditary Angioedema Sales Share by Application (2013-2018)
Figure Global Hospital Pharmacies Sales Growth (2013-2018)
Figure Global Online Pharmacies Sales Growth (2013-2018)
Figure Global Hereditary Angioedema Sales, Revenue and Growth Rate (2018-2023)
Table Global Hereditary Angioedema Sales Forecast by Regions (2018-2023)
Table Global Hereditary Angioedema Market Share Forecast by Regions (2018-2023)
Figure North America Sales Hereditary Angioedema Market Forecast (2018-2023)
Figure Europe Sales Hereditary Angioedema Market Forecast (2018-2023)
Figure Asia-Pacific Sales Hereditary Angioedema Market Forecast (2018-2023)
Figure South America Sales Hereditary Angioedema Market Forecast (2018-2023)
Figure Middle East and Africa Sales Hereditary Angioedema Market Forecast (2018-2023)
Table Global Hereditary Angioedema Sales Forecast by Type (2018-2023)
Table Global Hereditary Angioedema Market Share Forecast by Type (2018-2023)
Table Global Hereditary Angioedema Sales Forecast by Application (2018-2023)
Table Global Hereditary Angioedema Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List

Choose License Type